Immune reconstitution inflammatory syndrome due to Mycobacterium bovis bacillus Calmette-Guérin in infants receiving highly active antiretroviral therapy: A call for universal perinatal rapid HIV testing prior to administration of BCG immunization of neonates

Journal of Tropical Pediatrics

Volumn 56, Issue 4, 2009, Pages 280-283

  Koppel, Alexander ^a,b   Leonardo Guerrero, Jose ^b   Rives, Sarah ^c   Paniagua Torres, Noemi ^b   Sparrow, Celine ^b   Beck Sagué, Consuelo M ^b,d  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Department of Research   (Dominican Republic)

^c Francisco A Gonzalvo Hospital   (Dominican Republic)

^d Columbia University ^*  (United States)

Author keywords

BCG; HIV; Immune reconstruction inflammatory syndrome

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; ETHAMBUTOL; ISONIAZID; RIFABUTIN;

ABNORMAL RESPIRATORY SOUND; ARTICLE; BCG VACCINATION; BODY TEMPERATURE; BOVINE TUBERCULOSIS; BREATHING RATE; CASE REPORT; CD4 LYMPHOCYTE COUNT; COUGHING; DEHYDRATION; DELTOID MUSCLE; DERMATITIS; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; FAILURE TO THRIVE; FEEDING DISORDER; FEMALE; FEVER; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFANT; LUNG AUSCULTATION; LYMPHADENOPATHY; MALE; MYCOBACTERIUM BOVIS; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS; SEROLOGY; THRUSH; VAGINAL DELIVERY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BCG VACCINE; FEMALE; GUIDELINES AS TOPIC; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNIZATION; INFANT; MALE; WORLD HEALTH ORGANIZATION;

EID: 77955021621     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmp115     Document Type: Article

References (25)

1. Marais BJ, Gie RP, Schaaf HS, et al. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006;173:1078-90.
2. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004;8:636-47.
3. Walls T, Shingadia D. Global epidemiology of paediatric tuberculosis. J Infect 2004;48:13-22.
4. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:392-402.
5. Marais BJ, Gie RP, Hesseling AC, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006;118:e1350-9.
6. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006;367:1173-80.
7. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995;96(1 Pt 1):29-35.
8. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702.
9. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 2001;15:143-52.
10. Corbett EL, Marston B, Churchyard GJ, et al. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006;367:926-37.
11. Hesseling AC, Marais BJ, Gie RP, et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 2007;25:14-8.
12. Hesseling AC, Rabie H, Marais BJ, et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006;42:548-58.
13. Bannister C, Bennett L, Carville A. Evidence behind the WHO guidelines: hospital care for children: What is the evidence that BCG vaccination should not be used in HIV-infected children? J Trop Pediatr 2009;55:78-82.
14. World Health Organization. BCG Vaccine: WHO Position Paper. Weekly Epidemiologic Record 2004; 79:27-38.
15. Homsy J, Kalamya JN, Obonyo J, et al. Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital. J Acquir Immune Defic Syndr 2006; 42:149-54.
16. Palmer CJ, Dubon JM, Koenig E, et al. Field evaluation of the Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J Clin Microbiol 1999;37:3698-700.
17. Sherman GG, Stevens G, Jones SA, et al. Dried blood spots improve access to HIV diagnostics and care for infants in low-resource settings. J Acquir Immune Defic Syndro 2005;38:615-7.
18. Violari A, Paed FC, Cotton MF, et al. Early antiretroviral therapy and mortality among HIV-Infected infants. New Engl J Med 2008;359:2233-44.
19. Mak TK, Hesseling AC, Hussey GD, et al. Making BCG vaccination programmes safer in the HIV era. Lancet 2008;372:786-7.
20. Kroidl A, Huck K, Weinspach S, et al. Immune reconstitution inflammatory syndrome (IRIS) due to Bacille Calmette Guerin (BCG) in an HIV-positive child. Scand J Inf Dis 2006;38:716-8.
21. Siberry GK, Tessema S. Immune reconstitution syndrome precipitated by bacille Calmette Guerin after initiation of antiretroviral therapy. Ped Inf Dis J 2006;25:648-9.
22. Puthanakit T, Oberdorfer P, Punjaisee S, et al. Immune reconstitution syndrome due to bacillus Calmette-Guerin after initiation of antiretroviral therapy in children with HIV infection. Clin Inf Dis 2005; 41:1049-52.
23. Hesseling AC, Rabie H, Marais BJ, et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006;42:559-61.
24. Hesseling AC, Marais B, Gie RP, et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV infected children. Vaccine 2007;25:14-18.
25. Fallo A, Torrado L, Sánchez A. Delayed complications of Bacille Calmette-Guérin (BCG) vaccination in HIV-infected children. International AIDS Society Meeting (2005) www.ias-2005.org/planner/Presentations/ppt/ 749.ppt (27 March 2009, date last accessed).